Executive Sales Specialist (Human Array) UK, Ireland & North

England, United Kingdom

Auto‑apply with AI Apply

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life SciencesIndustries

Position Overview

Location Type: Remote (UK, Ireland, North)
Employment Type: Full-time
Salary: Not specified

Description: This role focuses on protecting, expanding, and creating new business within Illumina’s Human Array portfolio for the UK, Ireland, and North region. The Executive Sales Specialist will be the commercial subject matter expert, supporting large accounts, strategic deals, and building relationships with key customers and thought leaders. The goal is to achieve long-term revenue growth and profitable margins.

Requirements

Strong understanding of genomics and related technologies.
Experience in sales and account management.
Ability to develop and execute strategic sales plans.
Excellent customer relationship management skills.
Ability to identify and qualify sales opportunities.
Strong communication and presentation skills.

Responsibilities

Responsible for all aspects of customer relationship management, portfolio management, and proposal development.
Develop strategic plans to win new business, expand market share, and build upon existing programs.
Identify innovative and competitive solutions to customer problems.
Execute strategies and campaigns to target and win large human array opportunities.
Maintain regular interactions between customers and the Illumina management team.
Support large accounts and strategic deals within the subregion.
Gather intelligence and market insights.

Skills

Genomics

Sales

Account Management

Strategic Planning

Customer Relationship Management

Communication

Presentation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free